FindTrial
Sign In

Novel Risk-profiling Strategies for Prediction of Prognosis and Sudden Cardiac Death in Heart Failure

Novel Risk-profiling Strategies for Prediction of Prognosis and Sudden Cardiac Death in Heart Failure

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-POC-17011842
Enrollment
Unknown
Registered
2017-07-03
Start date
2017-07-01
Completion date
Unknown
Last updated
2017-07-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart failure

Interventions

Case series:Nil

Sponsors

The first Affiliated Hospital with Nanjing Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: This study will select patients of heart fialure with EF 35pg/ml and/or NT-proBNP >125pg/ml), at leaset one additional criterion:(1)relevant structural heart disease (LVH and /or LAE),(2)diastolic dysfunction.

Exclusion criteria

Exclusion criteria: 1. Hypertrophic cardiomyopathy; 2. Rheumatic heart disease; 3. Congenital heart disease; 4. pulmonary heart diseas; 5. Pericardial diseases and myocarditis; 6. Acute myocardial infarction in recent 3 months, including STEMI and NSTEMI; 7. Aortic dissection; 8. Severe hematologic disease including leukemia, lymphoma, aplastic anemia, etc.; 9. Autoimmune disease; 10. Malignant tumor; 11. hormone replacement; 12. application of other interventional clinical trial; 13. implantation of CRT-P/D or ICD.

Countries

China

Contacts

Public ContactJiangang Zou

The first Affiliated Hospital with Nanjing Medical University

jgzou@njmu.edu.cn+86 13605191407

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 21, 2026